Porres-Aguilar M, García CJ, Porres-Munoz M, García H

Language: English
References: 10
Page: 679-680
PDF size: 88.87 Kb.

Text Extraction

We have read with interest the recent original contributions published in your journal regarding the experience of liver transplantation (LT) in some of the most important tertiary referrals centers in Mexico. We would like to share some thoughts and concerns regarding the importance of the development of lung vascular disorders in the setting of liver disease/portal hypertension, since those disorders have been documented in the forms of portopulmonary hypertension (POPH) and hepatopulmonary syndrome (HPS), carrying significant morbidity and mortality, particularly in the perioperative setting of LT. Recent prospective studies have estimated the prevalence of POPH and HPS of 8.5% and 10-30%, respectively, especially in tertiary centers evaluating LT candidates.

REFERENCES

1. Rodriguez-Montalvo C, Tijerina-Gomez L, Flores-Villalba E, Cuevas-Estandia P, Del Real-Romo Z, Cisneros L, Castilleja F, et al. Twelve years of liver transplant at the San Jose Tec de Monterrey hospital. Rev Invest Clin 2011; 63(Suppl. 1): 73-8.

2. Perez-Rodriguez E, Munoz-Espinoza LE, Zapata-Chavira H, Nanez-Terreros H, Rositas-Noriega F, Hernandez-Guedea MA, Mercado-Moreira AB, Cordero-Perez P, et al. Orthotopic liver transplantation. Experience in the University hospital of Monterrey NL. Rev Invest Clin 2011; 63 (Suppl. 1): 79-84.

3. Cisneros G LE, López H PA, Muñoz R MR, Castilla V MP, Sebastian R MJ, Alvarez TGA, et al. Trasplante Hepático en la Unidad Médica de Alta Especialidad No. 25, IMSS Monterrery. Rev Invest Clin 2011; 63 (Suppl. 1). 67-72.

4. Hernandez-Dominguez JM, Holm-Corzo A, Santos-Caballero M, Porras-Ramos MA, Gomez-Casanova P, Perez-Molina L, Villasenor-Colin C, et al. Experience in liver transplantation (1996-2011) at the UMAE General Hospital Gaudencio Gonzalez Garza, National Medical Center, La Raza, Mexican Institute of Social Security, Mexico City. Rev Invest Clin 2011; 63 (Suppl. 1): 62-6.

5. Porres-Aguilar M, Altamirano JT, Torre-Delgadillo A, Charlton MR, Duarte-Rojo A. Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview. Eur Respir Rev 2012; 21: 223-33.

6. Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome: a liver-induced lung vascular disorder. N Engl J Med 2008; 358: 2378-87.

7. Elliott CG, Barst RJ, Porres-Aguilar M, Seeger W, Brown LM, Zamanian RT, Rubin LJ. Worlwide physician education and training in pulmonary hypertension. Pulmonary Vascular Diseases: the global perspective. Chest 2010; 137(Suppl. 6): 85S-94S.

8. Porres-Aguilar M, Zuckerman MJ, Figueroa-Casas JB, Krowka MJ. Portopulmonary hypertension:state of the art. Ann Hepatol 2008; 7: 321-30.

9. Swanson KL, Weisner RH, Nyberg SL, Rosen CB, Krowka MJ. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant 2008; 8: 2445-53.

10. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB. ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 2004; 24: 861-80.